Today: 23 March 2026
Subscribe
Browse Category

NASDAQ:SCNX 16 October 2025 - 24 October 2025

Scienture Holdings (SCNX) Stock Skyrockets on FDA Drug Launch – Will the Rally Last?

Scienture Shares Skyrocket 350% on FDA-Approved Drug Launch – What’s Next?

Scienture (NASDAQ: SCNX) soared 355% to close near $2.60 on Oct. 23, 2025, after announcing the launch of Arbli, the first FDA-approved liquid losartan. Shares fell about 25% after hours and swung between $0.83 and $2.60 on Oct. 24. The company secured distribution deals covering over 100 million patients and converted all convertible debt to equity earlier in October. Analyst coverage remains sparse, with a consensus “Sell” rating.
24 October 2025
·
Scienture Holdings (SCNX) Stock Skyrockets on FDA Drug Launch – Will the Rally Last?

Scienture Holdings (SCNX) Stock Skyrockets on FDA Drug Launch – Will the Rally Last?

Scienture Holdings (NASDAQ: SCNX) jumped up to 45% in pre-market trading on Oct. 23, 2025, after announcing its first commercial sales of Arbli, the only FDA-approved ready-to-use liquid losartan. Trading volume surged to 77 million shares, far above its 4 million average. Despite the spike, SCNX remains down over 90% for the year. The company recently eliminated all debt by converting debentures to equity.
23 October 2025
··
Scienture (SCNX) Stock Skyrockets on New FDA-Approved Blood Pressure Drug Launch

Scienture (SCNX) Stock Skyrockets on New FDA-Approved Blood Pressure Drug Launch

SCNX shares jumped over 30% in early trading Oct. 16 after Scienture announced Arbli, the first FDA-approved ready-to-use liquid losartan, is now available through major wholesalers. The stock hit an intraday high of $1.12 before trading near $0.71 by mid-day. Scienture recently secured a major rebate deal to drive Arbli’s adoption. Analysts remain cautious, citing weak financials and high volatility.
16 October 2025
··

Stock Market Today

  • Noteworthy Monday Options Activity: HOOD, SNDK, CYRX See Significant Volume
    March 23, 2026, 4:23 PM EDT. Options trading surged Monday for Robinhood Markets (HOOD), SanDisk Corp (SNDK), and CryoPort Inc (CYRX) among Russell 3000 components. HOOD saw 185,613 contracts trade, about 68.6% of its average daily volume, led by $80 calls expiring March 2026. SNDK handled 131,488 contracts, or 68.2% of usual volume, with $750 calls active. CYRX options hit 3,016 contracts, 64.9% of average daily shares, driven by $5 calls expiring December 2026. These figures reflect heavy market interest in call options expiring in 2026, signaling trader speculation on price moves. This level of activity impacts liquidity and may influence stock price volatility in the near term.
Go toTop